WICHITA, Kan.; HAIFA, Israel - Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies, is the lead investor in a $150 million Series E funding round for INSIGHTEC, a commercial-stage medical device company revolutionizing surgery with MRI-guided focused ultrasound. The investment, announced Thursday, will further marketing and commercialization for approved indications and research in Parkinson`s disease, Alzheimer`s disease, brain tumors, and various forms of cancer, using the company`s breakthrough technology to deliver treatment in a non-invasive way. It is also the first investment for Koch Disruptive Technologies...
|
